MyoLift QT Against NuFACE Trinity Plus, the Pro Adjacent Question
Medically reviewed by
4 independent reviewers
Andrew Conrad Barile, PT, DPT
Doctor of Physical Therapy (DPT) | Licensed Physical Therapist (PT) | CEO and Founder, Xtreem Pulse LLC
Read bio
Dr. Andrew Conrad Barile is a Doctor of Physical Therapy and the CEO and Founder of Xtreem Pulse LLC, the engineering company behind PureLift. He earned his Doctorate in Physical Therapy from Daemen College and is a licensed physical therapist.
He brings over two decades of clinical and entrepreneurial experience across physical therapy, craniosacral therapy and medical device innovation, built on a working knowledge of human anatomy and muscle physiology.
For PureLift LAB he reviews how current is delivered across all ten levels, from sub-sensory nanocurrent and skin-level microcurrent to motor-level EMS, and how the Infuse pass fits into the same ten-minute routine.
Bertica M. Rubio, M.D.
Board-Certified Physician, Dartmouth Medical School | Medical Director, Antiaging Regenerative Medicine Clinic
Read bio
Dr. Bertica M. Rubio is a board-certified physician and Medical Director of the Antiaging Regenerative Medicine Clinic in Redlands, California. She earned her Doctor of Medicine from Dartmouth Medical School and completed her pediatrics residency at UC Irvine Medical Center.
With decades of clinical experience, she specialises in age management medicine, regenerative medicine, wound healing and growth factor therapies, and her practice integrates evidence-based medical science with advanced aesthetic treatment.
For PureLift LAB she reviews articles for medical accuracy across the whole dial, from the gentle nanocurrent and microcurrent settings through to muscle-level EMS and the Infuse pass.
Daniel Grinberg, MD, FACS
Board-Certified Otolaryngologist | Head and Neck Surgeon | Fellow, American College of Surgeons | Mount Sinai
Read bio
Daniel Grinberg, MD, FACS is a board-certified otolaryngologist and head and neck surgeon at ENT and Allergy Associates in West Nyack, New York. He earned his medical degree from Columbia University College of Physicians and Surgeons.
He completed his otolaryngology residency at New York University Medical Center, serves as Assistant Clinical Professor at Mount Sinai School of Medicine, and is a Fellow of both the American College of Surgeons and the American Academy of Otolaryngology.
For PureLift LAB he brings a wider clinical lens, connecting at-home facial stimulation from microcurrent to EMS to the anatomy underneath, with the same rigour we apply to every device specification.
Prof. Dr. med. Ivo Buschmann
Chair of Angiology, Medizinische Hochschule Brandenburg | Clinic Director, University Clinic for Angiology
Read bio
Prof. Dr. med. Ivo Buschmann is Chair of Angiology at the Medizinische Hochschule Brandenburg Theodor Fontane and Clinic Director of the University Clinic for Angiology at the Brandenburg University Hospital.
He trained at the University of Hamburg, was a Max Planck Society Fellow at the Max Planck Institute for Heart and Lung Research, and held senior consultant posts at the Charite Universitatsmedizin Berlin before his appointment as Chair in 2016.
One of Europe's leading authorities on arteriogenesis, with over 150 peer-reviewed publications and US and EU patents, he reviews for PureLift LAB how the evidence on electrical stimulation is read and where its limits lie.
Share
MyoLift QT publishes the only load-referenced output figure in consumer microcurrent, and NuFACE has the wider ecosystem and the longer clearance history.
This article compares the two on what decides the result you actually see, such as:
- the one figure MyoLift publishes that almost nobody else does
- what 0.625 Hz means and why it is unusual
- the professional pedigree and what it is worth to a home user
- app dependence and recurring costs on both
- which one a serious home user should choose
and many more!
The MyoLift QT's filing is the single most useful public document in consumer microcurrent, and almost nobody reads it.
Key Points:
MyoLift QT publishes 350 microamps at 500 ohms in its FDA filing, with the load stated, which is rare in this category.
Its frequency is 0.625 Hz in Erase mode and 0.694 Hz in Educate mode, far lower than most devices in this market.
The QT is $229 for the Base version and $329 for Premium, where the difference is app access rather than hardware.
NuFACE Trinity+ is $395, with attachments around $160 each and the deepest clearance history in the category.
7E's clearance K213078 is held by Johari Digital Healthcare in India, which is normal and is not published on 7E's own site.
The figure that makes this comparison possible
Almost every device in this category quotes a current with no load, which makes the number uncomparable. The MyoLift QT is the exception.
Its FDA filing publishes 350 microamps at 500 ohms, along with 342 microamps at 2 kilohms and 320 at 10 kilohms, so you can see how the output holds up as resistance rises.
That is genuinely useful information and it is the kind of disclosure the rest of this market should be held to.
NuFACE's 335 microamps for the MINI+ comes with no load at all, so the two figures cannot be lined up precisely even though they look close.
An unusual frequency
The QT runs at 0.625 Hz in one mode and 0.694 Hz in the other, which is well under one pulse per second.
Most consumer devices in this space run considerably faster, and NuFACE's filing gives a default treatment frequency around 8.3 Hz.
Slower pulses at these currents produce a different sensation and a different treatment rhythm rather than a different category of effect, since both remain far below motor level.
It also reflects the professional microcurrent tradition 7E comes from, where slow, low, sub-sensory work is the explicit philosophy rather than an accident.
What professional pedigree buys a home user
7E Wellness builds treatment-room equipment, and the QT is its consumer device rather than a repackaged professional machine.
What comes across from that world is the protocol thinking: structured programmes, a defined course, and language about treatment series rather than daily gadgets.
What does not come across is the machine itself, since the professional 600 series is licence-gated and runs to $1,645.
7E also states plainly in its own FAQ that true microcurrent is sub-sensory and cannot cause a contraction of the muscle, which is a more honest description than most of this category offers.
Apps and pricing
The QT is $229 for Base and $329 for Premium, and the difference is app access rather than hardware, with the Base version's app access expiring after a trial period.
That is a recurring cost structure worth understanding before you buy the cheaper version and then discover the app was the product.
NuFACE Trinity+ is $395 with a free app, and its costs arrive as attachments and gel instead.
7E's ReStore gel runs $14 for 2 oz, $27 for 4 oz and $75 for 16 oz, and the company states gels are non-returnable. NuFACE's runs $35 to $80.
Where each is made
7E's clearance is held by Johari Digital Healthcare Limited in Jodhpur, India, with a Canadian contract manufacturer added to the FDA listing more recently. None of that appears on 7E's own site.
NuFACE publishes no country of manufacture either, and its filings list a California address as the specification developer.
Neither situation is unusual and neither is a criticism; it is simply information you can only get from the regulator rather than from the shop.
Which to buy
Buy the MyoLift QT if you want the only device in consumer microcurrent that publishes its output at a stated load, and if the professional protocol approach appeals. Buy the Premium version rather than Base if you want the app without a later decision.
Buy NuFACE Trinity+ if you want the wider ecosystem, the attachment path to red light, and the longest clearance record in the category.
Buy neither if what you want is muscle work, which both companies would tell you their devices do not do. Our own comparison against the 7E range is here.
This article sits inside our full map of the category, where we set out all 33 devices we track, what each one carries and what each brand publishes: Nine Technologies on One Dial, What the Rest of the Market Actually Carries.